NCT02642900

Brief Summary

Candida albicans is the most prevalent species in denture-related stomatitis (DS). There are several treatment options for this condition, including the use of antifungal agents such as nystatin and miconazole. The side effects and the increasing number of resistant species caused by the use of these drugs encourage the development of alternative therapies. Photodynamic Therapy (PDT) has been used as a promising treatment of stomatitis. In this randomized clinical trial, the effectiveness of PDT was evaluated. Patients in this study were allocated to two groups. One group was treated with nystatin, and the other group was treated with PDT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jul 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

October 7, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 30, 2015

Completed
Last Updated

December 30, 2015

Status Verified

December 1, 2015

Enrollment Period

1.6 years

First QC Date

October 7, 2015

Last Update Submit

December 25, 2015

Conditions

Keywords

Complete dentureCandida sppPhotodynamic therapy

Outcome Measures

Primary Outcomes (1)

  • Treatment evolution of participants with Candida-related denture stomatitis, treated with PDT or Nystatin, by numbers of colony forming units per milliliter (cfu/mL) recovered from the palatal mucosa, from baseline to end of treatment

    through study completion, an average of 45 days

Study Arms (2)

Nystatin 100.000 units

EXPERIMENTAL

Patients were treated with a topical antifungal nystatin oral suspension(1000.000 units) 5mL every six hours/14 days. Patients were instructed to rinse the solution for 5 minutes and then to spit the solution out. Samples were collected on days 7, 14 and 30 after the end of treatment (follow-up).

Drug: Nystatin 100.000 units

Photodynamic Therapy

ACTIVE COMPARATOR

Patients used mouthwash with methylene blue 0.005% for 20 minutes (pre-irradiation time). The palatal mucosa was irradiated using a low level laser with the following settings: wavelength of 660 nm, energy density of 120 J/cm ², output power of 40 milliwatt, 2 minutes per point. PDT was performed in two sessions (one session per week). Samples were collected immediately after each clinical procedure and 30 days after the second procedure (follow-up).

Procedure: Photodynamic Therapy

Interventions

evaluate the effectiveness of photodynamic therapy (PDT) in the treatment of denture stomatitis in complete denture wearers.

Also known as: photochemotherapy
Photodynamic Therapy

Control group treated with nystatin

Also known as: Nystatin
Nystatin 100.000 units

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • patients presenting denture-related stomatitis, confirmed by clinical and microbiological evaluation

You may not qualify if:

  • were based on the patients' medical history, and were excluded patients with a history of head and neck cancer, those with type III DS (classification proposed by Newton), and individuals who had received or were receiving treatment with antibiotics, antifungal agents or steroids for the past three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculdade de Odontologia da Universidade de São Paulo

São Paulo, São Paulo, 05508-000, Brazil

Location

MeSH Terms

Interventions

PhotochemotherapyNystatin

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsDrug TherapyPhototherapyMacrolidesLactonesOrganic Chemicals

Study Officials

  • Regina Tamaki, Profa. Dra.

    Associated Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professora Doutora

Study Record Dates

First Submitted

October 7, 2015

First Posted

December 30, 2015

Study Start

July 1, 2009

Primary Completion

February 1, 2011

Study Completion

July 1, 2011

Last Updated

December 30, 2015

Record last verified: 2015-12

Locations